Element Biosciences AVITI¿ 24 sequencing and spati
Posted Date:
Aug 11, 2026
Aug 27, 2026
Awarded Date:
No Awarded Date
| SetAside Type | ||
| Solicitation ID | Solicitation Title | Solicitation Office |
| 140D0426Q0826 | Element Biosciences AVITI¿ 24 sequencing and spati | |
| Synopsis | ||
|
The purpose of this acquisition is to enhance the shared research capabilities of the National Cancer Institute (NCI), Center for Cancer Research (CCR), by acquiring an Element Biosciences AVITI24 Sequencing System for joint operation by the CCR Genomics Core and the CCR High-Throughput Imaging Facility (HiTIF). .... Read More
|
||
| Office Location | Agency Name | Solicitation Base Posting Type |
| DEPARTMENTAL OFFICES | Combined Synopsis/Solicitation | |
